ASML vs HUBC

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

HUBC exhibits signs of severe financial distress, characterized by a Piotroski F-Score of 4/9 which barely maintains a 'stable' rating despite catastrophic operational metrics. The company is facing a critical liquidity crisis with a Current Ratio of 0.16 and a Quick Ratio of 0.08, indicating an inability to meet short-term obligations. A devastating 99.8% decline in share price over the last year, coupled with negative revenue growth (-3.80%) and massive profit margins of -187.97%, suggests a company in a death spiral. The lack of an Altman Z-Score and Graham Number reflects a balance sheet that is likely too degraded for standard valuation models.